775 related articles for article (PubMed ID: 26167074)
1. Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats.
Jia D; Yamamoto M; Otsuki M
World J Gastroenterol; 2015 Jul; 21(25):7742-53. PubMed ID: 26167074
[TBL] [Abstract][Full Text] [Related]
2. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
Nakano S; Kihara Y; Otsuki M
Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
[TBL] [Abstract][Full Text] [Related]
3. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
Nakano S; Tachibana I; Otsuki M
Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
[TBL] [Abstract][Full Text] [Related]
4. Effects of early decompression and cholecystokinin inhibition in rats with acute pancreatitis induced by bile-pancreatic-duct obstruction.
de Dios I; Urunuela A; Manso M
J Lab Clin Med; 2003 Apr; 141(4):265-71. PubMed ID: 12677172
[TBL] [Abstract][Full Text] [Related]
5. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.
Kanemitsu D; Sakagami J; Motoyoshi T; Nakajima T; Kataoka K
Pancreas; 2006 Mar; 32(2):190-6. PubMed ID: 16552340
[TBL] [Abstract][Full Text] [Related]
6. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
7. Effects of bee venom on cholecystokinin octapeptide-induced acute pancreatitis in rats.
Seo SW; Jung WS; Lee SE; Choi CM; Shin BC; Kim EK; Kwon KB; Hong SH; Yun KJ; Park RK; Shin MK; Song HJ; Park SJ
Pancreas; 2008 Mar; 36(2):e22-9. PubMed ID: 18376296
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral administration of protease inhibitor on pancreatic exocrine function in WBN/Kob rats with chronic pancreatitis.
Sugiyama M; Kobori O; Atomi Y; Wada N; Kuroda A; Muto T
Pancreas; 1996 Jul; 13(1):71-9. PubMed ID: 8783337
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic oral administration of the CCK receptor antagonist loxiglumide on exocrine and endocrine pancreas in normal rats.
Imoto I; Yamamoto M; Jia DM; Otsuki M
Int J Pancreatol; 1997 Dec; 22(3):177-85. PubMed ID: 9444548
[TBL] [Abstract][Full Text] [Related]
10. Effects of cholecystokinin and carbachol on membrane fluidity in pancreatic acini.
Wang ZH; Ohshio G; Okada N; Imamura T; Tanaka T; Kohmoto M; Yoshida M; Tanaka J; Arii S; Sasaoki T; Funaki N; Imamura M
Dig Dis Sci; 1996 Jul; 41(7):1511-7. PubMed ID: 8689933
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic exocrine secretion in acute experimental pancreatitis.
Niederau C; Niederau M; Lüthen R; Strohmeyer G; Ferrell LD; Grendell JH
Gastroenterology; 1990 Oct; 99(4):1120-7. PubMed ID: 2394333
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin-1 receptor protein up-regulation during pancreatic regeneration after acute haemorrhagic pancreatitis in rats.
Yoshikawa H; Nakamura H; Tashiro M; Yamaguchi T; Taguchi M; Fukumitsu K; Otsuki M
Eur J Clin Invest; 2004 Jul; 34(7):498-507. PubMed ID: 15255787
[TBL] [Abstract][Full Text] [Related]
13. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Jia D; Taguchi M; Otsuki M
Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
[TBL] [Abstract][Full Text] [Related]
14. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin blockade triggers earlier and enhanced intra-acinar oxygen free radical generation in acute pancreatitis induced by pancreatic duct obstruction in rats.
Uruñuela A; Manso MA; de la Mano AM; de Dios I
Clin Sci (Lond); 2003 Aug; 105(2):203-12. PubMed ID: 12713440
[TBL] [Abstract][Full Text] [Related]
16. Optimal timing for the oral administration of Da-Cheng-Qi decoction based on the pharmacokinetic and pharmacodynamic targeting of the pancreas in rats with acute pancreatitis.
Zhang YM; Zhu L; Zhao XL; Chen H; Kang HX; Zhao JL; Wan MH; Li J; Zhu L; Tang WF
World J Gastroenterol; 2017 Oct; 23(39):7098-7109. PubMed ID: 29093618
[TBL] [Abstract][Full Text] [Related]
17. Supramaximal CCK-58 does not induce pancreatitis in the rat: role of pancreatic water secretion.
Yamamoto M; Reeve JR; Green GM
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G964-74. PubMed ID: 17158258
[TBL] [Abstract][Full Text] [Related]
18. Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatitic rats.
Otsuki M; Nakano S; Tachibana I
Regul Pept; 1994 Jul; 52(2):85-95. PubMed ID: 7972939
[TBL] [Abstract][Full Text] [Related]
19. Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats.
Seo SW; Jung WS; Piao TG; Hong SH; Yun KJ; Park RK; Shin MK; Song HJ; Park SJ
World J Gastroenterol; 2007 Apr; 13(16):2298-304. PubMed ID: 17511027
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
